AI Article Synopsis
Article Abstract
Introduction: Insomnia or sleeplessness is a common disorder associated with morbidity and poor quality of life. Trataka is one of the six cleansing techniques of yoga. Literature suggests that trataka could help in relieving insomnia. A study was conducted to evaluate the effect of trataka on insomnia severity and quality of sleep (QoS) in people with insomnia.
Materials And Methods: Twenty-nine participants with insomnia were recruited, who underwent trataka (45 minutes per day daily) for a period of 10 days. Insomnia severity and QoS were assessed before and after the intervention using the Insomnia Severity Index (ISI) and The Pittsburgh Sleep Quality Index (PSQI), respectively.
Results: This study showed a significant reduction in ISI score and PSQI global score and its associated subscale scores except sleep medication scores after the intervention.
Conclusion: Trataka may be considered as a treatment modality in reducing insomnia severity and in improving QoS in people with insomnia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.explore.2020.09.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A multi-site feasibility study of a stepped-care telehealth intervention for depression and anxiety in post-treatment cancer survivors at community cancer clinics (WF-30917CD).
J Cancer Surviv
January 2025
Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Purpose: This feasibility study estimated accrual, retention, adherence, and summarized preliminary efficacy data from a stepped-care telehealth intervention for cancer survivors with moderate or severe levels of anxiety and/or depressive symptoms.
Methods: Participants were randomized to intervention or enhanced usual care (stratified by symptom severity). In the intervention group, those with moderate symptoms received a cognitive-behavioral therapy (CBT) workbook/6 bi-weekly check-in calls (low intensity) and severe symptoms received the workbook/12 weekly therapy sessions (high intensity).
Polysomnographic findings and psychiatric symptoms in patients with comorbid insomnia and sleep apnea: a retrospective study focusing on sex differences.
Sleep Breath
January 2025
Department of Psychiatry, Chungnam National University Hospital, 282 Munhwa-ro, Jung-gu, Daejeon, 35015, South Korea.
Purpose: Comorbid insomnia and obstructive sleep apnea (COMISA) present significant clinical challenges, given their overlapping symptoms and detrimental effects on health. Only a few studies have explored sex differences in patients with obstructive sleep apnea (OSA) and COMISA. This retrospective study investigated sex differences in psychiatric symptoms and polysomnographic findings between patients with COMISA and those with OSA alone.
View Article and Find Full Text PDFClinical effects of acupuncture treatment for prevention of insomnia-induced stroke: A large-scale cohort study.
J Tradit Complement Med
January 2025
Department of Chinese Medicine, China Medical University Hospital, Taichung City, 40447, Taiwan.
Article Synopsis
- Recent research indicates a link between insomnia and a higher risk of stroke, prompting investigation into non-drug treatments like acupuncture.
- A study using data from Taiwan's National Health Insurance Database found that patients with insomnia who received acupuncture had a lower incidence of stroke compared to those who did not.
- Specifically, acupuncture patients showed a reduced stroke risk with better outcomes for those who underwent more sessions, suggesting a dose-response relationship in treatment effectiveness.
TAK-925 (danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-Induced Respiratory Depression and Sedation Without Affecting Analgesia in Healthy Adult Males.
Anesthesiology
January 2025
Takeda Development Center Americas, Inc., Lexington, MA, USA.
Background: Orexin neuropeptides help regulate sleep/wake states, respiration, and pain. However, their potential role in regulating breathing, particularly in perioperative settings, is not well understood. TAK-925 (danavorexton), a novel, orexin receptor 2-selective agonist, directly activates neurons associated with respiratory control in the brain and improves respiratory parameters in rodents undergoing fentanyl-induced sedation.
View Article and Find Full Text PDFStudy Objectives: 1) To determine the efficacy of Cognitive Behavioral Therapy for Insomnia (CBT-I) for improving insomnia, alcohol-related outcomes, and daytime functioning at post-treatment and at 3- and 6-month follow-up, in a largely African American Veteran sample; 2) Evaluate whether improvement in insomnia is associated with a reduction in alcohol-related outcomes post-treatment.
Methods: An RCT of CBT-I (n = 31) compared to Quasi-Desensitization therapy (QDT, n = 32), eight weekly in-person sessions, with assessments at baseline, end of treatment (8 weeks), and 3- and 6-months post-treatment. Primary outcomes were the Insomnia Severity Index (ISI) total score, and Percent Days Abstinent (PDA).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!